Evidence map›Paper›PMID 29664038›Full record

ArticleThe Indian journal of medical research2017

Shyam Narayan, Chandreshwar Prasad Thakur, Shiv Bahadur, Meenakshi Thakur, Shashi Nath Pandey, Ajit Kumar Thakur, Dipendra K Mitra, Pulok K Mukherjee

Abstract read
In one paragraph

Article in The Indian journal of medical research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shyam NarayanDivision of Microbiology, Rajendra Memorial Research Institute of Medical Sciences, Patna, India.
Chandreshwar Prasad ThakurBalaji Utthan Sansthan, Kala-azar Research Center, Patna, India.
Shiv BahadurDepartment of Pharmaceutical Technology, School of Natural Product Studies, Jadavpur University, Kolkata, India.
Meenakshi ThakurBalaji Utthan Sansthan, Kala-azar Research Center, Patna, India.
Shashi Nath PandeyBalaji Utthan Sansthan, Kala-azar Research Center, Patna, India.
Ajit Kumar ThakurDivision of Microbiology, Rajendra Memorial Research Institute of Medical Sciences, Patna, India.
Dipendra K MitraDepartment of Transplant Immunology & Immunogenetics, Division of Cellular Immunology, All India Institute of Medical Sciences, New Delhi, India.
Pulok K MukherjeeDepartment of Pharmaceutical Technology, School of Natural Product Studies, Jadavpur University, Kolkata, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND &

objectivesThe existing antileishmanial drugs for complete cure of visceral leishmaniasis (kala-azar) are limited. The available drugs are either toxic or less effective leading to disease relapse or conversion to post-kala-azar dermal leishmaniasis. Several herbal extracts have been shown to have antileishmanial activity, but a herbal drug may not always be safe. In the present study, the extract of Cedrus deodara leaves has been standardized and tested for immunomodulatory antileishmanial activities.

methodsThe extracts of C. deodara leaves with different solvents such as benzene, chloroform, ethyl acetate and methanol were made by soxhlation process. Solvents were removed under reduced pressure and temperature using rotary evaporator. The antileishmanial bioassay test was performed with in vitro maintained parasites. Immunomodulatory activity of different extracts was tested by flow cytometry. Standardization of the effective fraction was performed with Linalool as a marker compound through reverse-phase high-performance liquid chromatography.

resultsThe extract with the use of benzene solvent showed strong antileishmanial activities within a dose 25-200 μg/ml culture with non-significant haemolytic activities and significant immunomodulant activities against the host cells. Linalool was found to be 1.29 per cent in the effective extract of C. deodara. INTERPRETATION &

conclusionsThe antileishmanial activity of C. deodara, as assessed by bioassay testing on. LEISHMANIA DONOVANI: parasites and immunomodulatory effect of benzene extract of leaves on host cells indicated that it might be a potential new safe therapeutic target to cure the visceral leishmaniasis.

Indexed as

AnimalsAntioxidantsAntiprotozoal AgentsCedrusHumansLeishmania donovaniLeishmaniasis, VisceralPlant ExtractsPlant LeavesAntioxidantsAntiprotozoal AgentsPlant ExtractsArginase - Cedrus deodara - linalool - reverse-phase high-performance liquid chromatography - visceral leishmaniasis

Identifiers

PMID29664038
PMCPMC5926351

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.